64859-36-5 Usage
Description
(3-TERT-BUTOXY)BENZALDEHYDE, also known as (3-tert-butoxy)benzaldehyde, is a chemical compound with the molecular formula C14H20O2. It is an aromatic aldehyde featuring a tert-butoxy group attached to the benzene ring, known for its strong, sweet, floral odor. (3-TERT-BUTOXY)BENZALDEHYDE is flammable and should be handled with care due to its potential harmful effects if inhaled, ingested, or in contact with the skin.
Uses
Used in Pharmaceutical Industry:
(3-TERT-BUTOXY)BENZALDEHYDE is used as a chemical intermediate for the synthesis of various organic compounds and in the production of pharmaceuticals. Its unique chemical structure makes it a valuable component in the development of new drugs and medications.
Used in Fragrance Industry:
(3-TERT-BUTOXY)BENZALDEHYDE is used as a fragrance ingredient in the cosmetic and personal care industry. Its strong, sweet, floral odor contributes to the creation of various scents for perfumes, lotions, and other personal care products.
Used in Flavoring Industry:
(3-TERT-BUTOXY)BENZALDEHYDE is also used as a flavoring agent in the food industry. Its distinct flavor profile adds depth and complexity to a variety of food products, enhancing the overall taste experience for consumers.
Check Digit Verification of cas no
The CAS Registry Mumber 64859-36-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,8,5 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 64859-36:
(7*6)+(6*4)+(5*8)+(4*5)+(3*9)+(2*3)+(1*6)=165
165 % 10 = 5
So 64859-36-5 is a valid CAS Registry Number.
64859-36-5Relevant articles and documents
TARGETING NANOPARTICLES
-
Paragraph 00159; 00161, (2018/11/22)
Disclosed herein is a composition comprising a plurality of liposomes having an average diameter of less than 400 nanometers, wherein the plurality of liposomes comprise: a first lipid or phospholipid; a second lipid or phospholipid which is derivatized with a polymer; and a sterically bulky excipient capable of stabilizing the liposomes; a third lipid or phospholipid derivatized with a polymer terminated with an integrin targeting component; DSPE or a fourth lipid or phospholipid derivatized with a group binding a contrast enhancing agent wherein the plurality of liposomes optionally encapsulates a payload component consisting of one or more bioactive agents.
